These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36181124)

  • 61. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
    Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
    J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex.
    Lee HJ; Kim KS; Jeong JS; Kim KN; Lee BC
    BMC Anesthesiol; 2015 Jan; 15():7. PubMed ID: 25971394
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rocuronium with sugammadex as a rescue reversal agent to solve conflicting recommendations for thyroid or parathyroid surgery. A prospective study.
    Marquet Y; Philippe A; Toussaint S; Abdallah SB; Morel-Fatio E; Baillard C
    Anaesth Crit Care Pain Med; 2023 Aug; 42(4):101214. PubMed ID: 36889437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of reversal of residual neuromuscular blockade on the amplitude of motor evoked potentials: a randomized controlled crossover study comparing sugammadex and placebo.
    Venkatraghavan L; Royan N; Boyle SL; Dinsmore M; Lu N; Cushman K; Massicotte EM; Prabhu A
    Neurol Sci; 2022 Jan; 43(1):615-623. PubMed ID: 34041634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reversal of neuromuscular blockade by sugammadex does not affect EEG derived indices of depth of anesthesia.
    Illman H; Antila H; Olkkola KT
    J Clin Monit Comput; 2010 Oct; 24(5):371-6. PubMed ID: 20734116
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recovery time after sugammadex reversal of rocuronium-induced muscle relaxation for electroconvulsive therapy is independent of cardiac output in both young and elderly patients.
    Kadoi Y; Nishida A; Saito S
    J ECT; 2013 Mar; 29(1):33-6. PubMed ID: 23052151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
    Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sugammadex for reversal of rocuronium-induced neuromuscular blockade during alfaxalone anesthesia in dogs.
    Chen IY; Sugita C; Wei Y; Daimaruya N; Itami T; Sano T; Yamashita K
    Vet Anaesth Analg; 2023 Nov; 50(6):485-491. PubMed ID: 37648629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].
    Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289
    [No Abstract]   [Full Text] [Related]  

  • 73. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
    Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
    BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postoperative impairment of motor function at train-of-four ratio ≥0.9 cannot be improved by sugammadex (1 mg kg-1).
    Baumüller E; Schaller SJ; Chiquito Lama Y; Frick CG; Bauhofer T; Eikermann M; Fink H; Blobner M
    Br J Anaesth; 2015 May; 114(5):785-93. PubMed ID: 25586724
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Individual pharmacometric analysis for sugammadex reversal and re-administration of neuromuscular blockade.
    Kashima Y; Masui K
    J Anesth; 2020 Oct; 34(5):786-789. PubMed ID: 32656687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety and Efficacy of Rocuronium With Sugammadex Reversal Versus Succinylcholine in Outpatient Surgery-A Multicenter, Randomized, Safety Assessor-Blinded Trial.
    Soto R; Jahr JS; Pavlin J; Sabo D; Philip BK; Egan TD; Rowe E; de Bie J; Woo T
    Am J Ther; 2016; 23(6):e1654-e1662. PubMed ID: 25768376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
    Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
    Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.